new warnings about Chantix and an increased risk of heart troubles in patients with heart disease

August 2011

Please see updated FDA safety information regarding the risk of cardiovascular events with Chantix (varenicline).

People will worry about new warnings about Chantix and an increased risk of heart troubles in patients with heart disease.

FDA says there MIGHT be a higher risk...but this is controversial. The increase in heart risk is likely to be small...if it exists at all.

Chantix (varenicline) is still a good smoking cessation option...and is FAR less dangerous than continuing to smoke.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Erectile Dysfunction avoiding errors when dispensing erectile dysfunction meds (Viagra, Cialis, etc)
Medication Errors new checks and balances to avoid mishaps with risperidone (Risperdal) and ropinirole (Requip)
Education and Training a new electronic CE reporting system called CPE Monitor
Smoking Cessation new warnings about Chantix and an increased risk of heart troubles in patients with heart disease
Cardiology two new blood thinners, Brilinta (ticagrelor, tye-KA-grel-or) and Xarelto (rivaroxaban, zuh-REL-toe)
Vitamins & Minerals dispensing vitamin B12 supplements
Hepatitis C two new drugs for hepatitis C, Incivek (telaprevir, in-SEE-veck) and Victrelis (boceprevir, vic-TREL-is)
Statins if statins increase the risk of diabetes
Sunscreens New rules for sunscreens
Thrush Topical antifungals for oral thrush
Antibiotics which oral erythromycin to dispense
Dispensing how to handle Rxs for butalbital-containing meds (Fiorinal, Fioricet, Esgic-Plus, etc)